Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. - Wikidata - awgldk - TriplyDB

Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.

Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.

http://www.wikidata.org/entity/Q33732199

about

Molecular phenotypes of colorectal cancer and potential clinical applications Functional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator Phenotype The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases Biomarker correlation network in colorectal carcinoma by tumor anatomic location.Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression KRAS and BRAF mutational status in colon cancer from Albanian patients.Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.Association between molecular subtypes of colorectal cancer and patient survival Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment.A randomized Phase II clinical study of combining panitumumab and bevacizumab, plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mut EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells.Molecular markers predictive of chemotherapy response in colorectal cancer The mutation rates of EGFR in non-small cell lung cancer and KRAS in colorectal cancer of Chinese patients as detected by pyrosequencing using a novel dispensation order.Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.111In-cetuximab as a diagnostic agent by accessible epidermal growth factor (EGF) receptor targeting in human metastatic colorectal carcinoma Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival.Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies MicroRNA MIR21 and T Cells in Colorectal Cancer.Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer.Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study.A meta-analysis of MSI frequency and race in colorectal cancer.Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.Precision medicine in colorectal cancer: evolving genomic landscape and emerging consensus.Investigation of correlation between mutational status in key EGFR signaling genes and prognosis of stage II colorectal cancer.Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer.Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer.Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer.Tumor Expression of Calcium Sensing Receptor (CASR) and Colorectal Cancer Survival: Results from the Nurses' Health Study and Health Professionals Follow-Up Study.Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.

P2860

Q26785725-13B1E060-93DD-483A-8AE2-6F11CEAA6034 Q28551197-968E5438-21B3-40DD-A501-FC8B6149169B Q33630343-93A9A318-39CE-4F01-86F6-25451F324886 Q33808553-56BB1A3D-1E3C-4443-86C8-FFF34966A937 Q33992378-39A4BBD5-5B21-4DA0-9BBD-73AF18BFDE49 Q34346064-1C5FA05D-443E-45D8-83F0-E5BB74B575F0 Q34502713-D47DBFC9-2DD1-4554-97FC-AB5AECE5740D Q34759064-690436D7-C354-4EB8-A052-6D9528D0B3B6 Q35218647-9DB05BCA-FCB4-4E3C-98D4-EE8917BCE9BA Q35624250-C1E90204-E8B4-4277-A1B2-9473E09397FF Q35674250-3067017E-817D-4491-95FB-2228E4BCB7E0 Q35761956-E45F127E-F2A8-45D2-A8EB-4419850C7959 Q35782746-776ADEAB-8569-4121-B39C-7EF9427AD388 Q35956384-DFE4CB59-6470-4801-9635-BA02BF9DE585 Q35962621-0977F17C-159D-42C4-BF4D-C88CADE269CA Q36140886-C69250FD-3421-4207-8E8B-386DD160666D Q36223053-13273367-C1F4-401E-8CC4-0B1463904EA8 Q36267137-2312C402-896B-4071-B253-B1D69F793F32 Q36436728-7ACD0DAD-8C7D-45F1-83AD-6F850D043A71 Q36472281-3F4CF746-F776-4682-9E10-9E01175C929B Q36487348-13E844A3-BC21-4895-B2C8-F7AB7302DC7D Q36750694-E1A3541B-0167-419F-A9A4-D9BDB55319E4 Q36883777-95354D00-E01F-43CF-9A3B-68BB92396757 Q36954147-BB9F515B-9961-4497-B8C9-49386793768E Q37225530-61F12664-59AA-4097-B275-778ADC8A8DEC Q37241845-D513D1CA-6376-4BDD-9E92-EF85D6468B5E Q37376333-73A9A55C-1A93-4C28-A6D5-E6FA5C3A1E0C Q37457496-35F1DD00-856B-406D-B9C5-42D3EB6327F5 Q37688202-2A420541-89E8-4C08-8442-E7564AADEDB9 Q38580566-D4B7B84A-7200-4E32-AA4C-5B7A2AE836A6 Q38661498-00253C24-9BEB-4A2F-8F26-D0E34E53164B Q38924496-E46CB722-F472-4378-893E-E47CBAC21F36 Q38935141-0F71D4D1-0C80-4F44-BFB5-92DCBA9E9FAE Q39139086-89C3208D-742F-47C5-9890-FBD170263965 Q39217446-4B649911-1A83-4C5A-871C-8DEF5ED327BC Q39294187-40123531-7D82-46F9-A21E-D8EB8DC25455 Q39796293-4637A537-B405-4D4A-910A-205D4A127E48 Q40063743-E20BC44E-092C-4BA6-A63D-5E2D2933288A Q40244514-782DC356-C072-4A68-AD3D-AAAFDDFED578 Q40603067-3185BD3E-1384-479C-AFF1-0523D35520E6

P2860

Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.

http://www.wikidata.org/entity/Q33732199

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Analyses of clinicopathologica ...... t study and literature review.

@ast

Analyses of clinicopathologica ...... t study and literature review.

@en

type

label

Analyses of clinicopathologica ...... t study and literature review.

@ast

Analyses of clinicopathologica ...... t study and literature review.

@en

prefLabel

Analyses of clinicopathologica ...... t study and literature review.

@ast

Analyses of clinicopathologica ...... t study and literature review.

@en

P1433

Q33732199-493B7953-14C3-42E8-9A2E-B6A7806D9D32

P1476

Q33732199-A7D8E9A7-456E-4D66-A195-348116C6DD09

P2093

Q33732199-03201ECF-AF7E-4E97-9042-8F8632240348

Q33732199-0DCCA458-79FA-4C2B-A5A4-654E3A7B7CC1

Q33732199-3380A515-C71D-452C-8F04-3140663707F3

Q33732199-4B52E16C-150F-4471-9930-00A8FA4F7A14

Q33732199-74A45B1E-A93E-47A3-8179-74690DF414B7

Q33732199-7CA3CEF9-9F4D-45E4-9427-3A6E62CFD4CC

Q33732199-86C57302-07DF-4070-8A27-ACA1D100C66A

Q33732199-8EACCA60-4AF0-4C78-9AE7-AD59A84EB157

Q33732199-9EDA7E2A-4A5E-4249-B0C1-04BDA38E762B

Q33732199-A343F746-B3B0-4075-8C6C-0B33456D63E0

P2860

Q33732199-025920A5-9B6B-48A0-B4E4-33AEA653B616

Q33732199-0D6CBF75-37F9-4B93-BF57-EDF8C7A53EA3

Q33732199-106A4E34-B960-4B6F-9504-138FE3AE95CB

Q33732199-1117046D-7E87-4E30-8AA2-9F269B7EA092

Q33732199-12AE9F6E-D960-42A1-83DC-A4E58249B47C

Q33732199-14EF9681-F008-4A8B-B0D5-4F16DD022BD7

Q33732199-160B3E7E-16FC-4AA1-999E-0E0459636633

Q33732199-172A5B94-32DA-45F6-AD4B-36BAA34E6657

Q33732199-19DFEB92-14DD-45F9-8BEC-1DBE72D7E1E5

Q33732199-1B4FFA52-51AD-431C-BAA5-4EAAB6999800

P2888

Q33732199-36CC6B7D-9C3E-4C3C-B736-581512E97261

P304

Q33732199-8872C710-4880-4052-B955-69DFC9423367

P31

Q33732199-9B77DD14-0B9F-4326-AC3F-F1623B0FF48D

P356

Q33732199-A4534AD4-B9F5-45E9-AD69-6DAFE6EA0650

P478

Q33732199-0C7D23D7-1F2E-4D93-A604-B28D3D805681

P50

Q33732199-19F9FD2A-BC89-40B3-B9A6-ACF49DADC330

Q33732199-99C653B2-6D60-4E6D-8BC2-6468845BFBDA

P577

Q33732199-B910CA4A-A4FD-43AA-8768-C684BB67D731

P5875

Q33732199-F5AA75BB-B8DC-4A0F-BB1A-7B16D2CB4505

P6179

Q33732199-A048A256-DD78-4809-BB61-B9C4CB4D006F

P698

Q33732199-89D53884-70C7-42CD-A645-EBC2E05CED95

P921

Q33732199-33627EE4-EEDC-4EE5-B10A-289F37861AA8

P932

Q33732199-174A2E18-F971-42BA-9FB3-8B10D3E629D0

P356

1476-4598-13-135

P1433

Molecular Cancer

P1476

Analyses of clinicopathologica ...... t study and literature review.

@en

P2093

Adam J Bass

http://www.w3.org/2001/XMLSchema#string

Andrew T Chan

http://www.w3.org/2001/XMLSchema#string

Aya Kuchiba

http://www.w3.org/2001/XMLSchema#string

Kana Wu

http://www.w3.org/2001/XMLSchema#string

Katsuhiko Nosho

http://www.w3.org/2001/XMLSchema#string

Kevin M Haigis

http://www.w3.org/2001/XMLSchema#string

Mai Yamauchi

http://www.w3.org/2001/XMLSchema#string

Paul Lochhead

http://www.w3.org/2001/XMLSchema#string

Reiko Nishihara

http://www.w3.org/2001/XMLSchema#string

Seungyoun Jung

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field

Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology

Comprehensive molecular characterization of human colon and rectal cancer

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.

P2888

1476-4598-13-135

P304

135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-13-135

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Charles S. Fuchs

Jeffrey A Meyerhardt

P577

2014-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262781238

http://www.w3.org/2001/XMLSchema#string

P6179

1043855448

http://www.w3.org/2001/XMLSchema#string

P698

24885062

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4051153

http://www.w3.org/2001/XMLSchema#string